CASI Pharmaceuticals to Present Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting on December 7, 2025 in Orlando, Florida View Press[...]

CASI Pharmaceuticals Inc. published this content on November 04, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 08, 2025 at 00:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]